Mary Laughlin

Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood.

J. Kurtzberg, J. Reems, S. Spellman, 2011, Cytotherapy.

Allogeneic Effector Cell Populations Separating GVL from GVHD

R. Negrin, H. Lazarus, Mary Laughlin, 2013 .

Characteristics of Graft-versus-Host Disease (GvHD) after Post-transplant Cyclophosphamide versus Conventional GvHD Prophylaxis.

M. Perales, J. Pidala, C. Abboud, 2022, Transplantation and cellular therapy.

Eighth Annual International Umbilical Cord Blood Transplantation Symposium, San Francisco, California, June 3-5, 2010.

J. Kurtzberg, Mary Laughlin, J. Mcmannis, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Early Cytomegalovirus Reactivation in Cord Blood Stem Cell Recipients in the Current Era

Riches, M. Boeckh, H. Lazarus, 2016 .

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.

J. Kurtzberg, E. Halperin, P. Rubinstein, 1996, The New England journal of medicine.

Umbilical cord blood transplantation.

J Wagner, W. Tse, J. Warner, 2009, Cancer treatment and research.